A B S T R A C T The lymphocyte transformation responses to purified preparations of two extracellular products of group A streptococci (blastogen A and nuclease B), to phytohemagglutinin, and to Candida albicans antigen were measured in tonsillar and peripheral blood lymphocytes from patients with rheumatic heart disease (RHD) and suitably matched nonrheumatic (control) subjects.
A B S T R A C T The lymphocyte transformation responses to purified preparations of two extracellular products of group A streptococci (blastogen A and nuclease B), to phytohemagglutinin, and to Candida albicans antigen were measured in tonsillar and peripheral blood lymphocytes from patients with rheumatic heart disease (RHD) and suitably matched nonrheumatic (control) subjects.
The mean phytohemagglutinin dose responses of tonsillar and peripheral lymphocytes from RHD patients were essentially indistinguishable from those of controls. In contrast, the responses of tonsillar and peripheral blood lymphocytes to the two extracellular products of group A streptococci were significantly lower in RHD patients than in nonrheumatic control subjects. Candida antigen produced very little stimulation of lymphocytes in any of the subjects.
The geometric means of antibody levels against streptolysin 0, nuclease B, and nicotinamide adenine dinucleotidase showed no consistent differences between the control group and the group of RHD subjects. Group A streptococci were isolated from the tonsils of -25% of both groups of subjects.
The RHD patients clearly had a depressed cellular immune response to the two purified streptococcal extracellular antigens. The equal frequency in recovery of group A streptococci from tonsils and the absence of consistent difference in titers of humoral antibodies to streptococcal extracellular antigens, particularly nuclease B, suggest that this differential response is not Dr. L. W. Wannamaker is a Career Investigator ofthe American Heart Association.
INTRODUCTION
The developmoent of acute rheumatic fever (ARF)1 and rheumatic heart disease (RHD) is generally held to involve some reaction of the immune system to group A streptococci or their products. The development ofantibodies crossreacting with streptococcal cellular constituents and with components of cardiac cells (1) , as well as alterations in various aspects of the cellular immune response (2) (3) (4) (5) (6) (7) (8) is, at least, presumptive evidence for immune mechanisms in the pathogenesis of rheumatic heart injury.
The changes in cellular immune function are diverse and intriguingly complex. Leukocyte migration inhibition in response to streptococcal membranes is increased in ARF and may persist for at least 5 yr after the initial attack (7). The one-way mixed lymphocyte culture response of ARF cells to allogeneic lymphocytes may be depressed (8) . Several reports indicate altered lymphocyte transformation response to streptococcal antigens in poststreptococcal disease. Using either whole organisms or streptococcal substances in various stages of impurity, a depressed lymphoproliferative response has generally been observed in ARF and in RHD (2) (3) (4) (5) (6) . However, other workers have reported an elevated blastogenic response in ARF and RHD (9, 10) . The complexity of the streptococcal preparations used in these various studies makes it difficult 1Abbreviations used in this paper: ARF, acute rheumatic fever; PHA, phytohemagglutinin; RHD, rheumatic heart disease.
to interpret the results. Studies with purified substances might resolve some of these discrepancies.
The development of ARF and RHD is apparently a consequence of group A streptococcal infections of the upper respiratory tract; infections with group A streptococci at other sites, e.g., skin, do not lead to these complications (11) . The role of the tonsils in this process is unknown, but it is possible that local factors could be important in the pathogenetic process leading to heart damage. For example, tonsillar lymphocytes may be a different subpopulation(s) and/or may respond to streptococcal antigens in a different manner than lymphocytes of the peripheral blood (12) . In earlier studies of the blastogenic response of tonsillar lymphocytes to impure preparations of streptococcal products, conflicting findings of their reactivity have been reported (13, 14) .
In this investigation the responses of tonsillar and peripheral blood lymphocytes from RHD patients were compared with those from nonrheumatic patients. Homogeneous preparations of two streptococcal extracellular products were used: streptococcal blastogen A (15) , a product recently shown to have mitogenic properties, and streptococcal nuclease B,2 an antigen that specifically stimulates previously sensitized lymphocytes. Phytohemagglutinin (PHA) and a preparation of Candida albicans antigen were used respectively, as nonspecific mitogen and specific antigen controls. The response oftonsillar and peripheral blood lymphocytes to both streptococcal antigens was markedly depressed in subjects with RHD as compared to a control group. The alteration more likely was not a consequence of differential exposure of the subjects to streptococcal antigens.
METHODS
Antigens. Streptococcal blastogen A and streptococcal nuclease B were purified from the crude extracellular products ofgroup A streptococcal strain C203S3 as previously described (15 blood agar plates. After overnight incubation at 370C, the streptococcal colonies were categorized as a-or f8-hemolytic and colonies exhibiting f8-hemolysis were isolated and serologically grouped (19) .
Lymphocyte transformation assay. Blastogenic stimulation was measured by [3H]thymidine incorporation by a gradient-separated monocyte population from peripheral blood and tonsils. The tonsils were minced with scissors, forced through a stainless steel screen and resuspended in Eagles' minimal essential medium (Grand Island Biological Co., Grand Island, N. Y.) containing 100 U/ml of penicillin, 100 ug/ml streptomycin, 50 ,g/ml of gentamycin, and 2 mmol/ml L-glutamine (MEM-PSG). The cell suspension was fractionated by centrifugation on a Ficoll-Hypaque gradient as previously described (15) . The samples of blood were diluted with an equal volume of MEM-PSG and the monocyte population isolated in the same manner. Triplicate 100-,ul samples of each antigen dilution (in MEM-PSG-5% fetal calf serum), were transferred to wells of standard tissue culture microtiter plates containing 105/100 ,ul lymphocytes. The PHA plates were incubated for 3 d, and the microbial preparations for 5 d at 37'C in an atmosphere containing 5% CO2. At these times, 0.5 uCi of [methyl-3H]thymidine was added and the plates incubated further for 18 h. Controls without antigen or PHA were included in each run. The cells were harvested and washed on glass fiber paper using a semiautomatic cell harvester. The radioactivity was measured in a toluene-based cocktail by scintillation counting.
Population study. Tonsillar tissue and samples of peripheral blood were obtained with the informed consent of individuals residing in Cairo, Egypt, who were scheduled for tonsillectomy on the advice of their physicians. The diagnosis of RHD was confirmed by history and careful physical examination. In patients with RHD, tonsillectomy was performed an average of 2.3 yr (1-5 yr) after the last clinically diagnosed attack of rheumatic fever. None of the rheumatic patients was in heart failure or showed evidence of rheumatic activity. None was taking medication other than penicillin. None of the rheumatic or nonrheumatic patients exhibited signs of frank nutritional deficiency. 23 control subjects were matched by age and socioeconomic status with 20 RHD patients. A detailed history and physical examination were carried out on control subjects to exclude a past history suggestive of rheumatic fever and evidence of subclinical RHD. The average ages of the RHD group and the control group were 18.1 and 16.0 yr, respectively. The study was carried out during annual visits to Cairo over a period of 3 yr. The results for each of the years were similar.
RESULTS
Lymphocyte blastogenic response. The mean response of peripheral blood lymphocytes to PHA in the group of RHD patients was indistinguishable from that of the control subjects (Fig. 1) . The tonsillar lymphocyte response was also very similar in both groups (Fig. 2) although the dose-response relationships were markedly different from those of the peripheral blood lymphocytes. The proliferation of the tonsil-derived cells was inhibited to a significantly greater extent by higher levels of the lectin. The similarity in response to this nonspecific T cell mitogen suggests that the proportion of lymphocytes capable of a proliferative response was similar in the RHD and control groups. The blastogenic response of lymphocytes to the streptococcal extracellular antigens was different in the two groups of patients. Streptococcal blastogen A stimulated the response of lymphocytes from control subjects to a greater extent than those from the RHD group (Figs. 3 and 4 ). This lesser response was observed in peripheral blood and tonsillar lymphocytes from RHD subjects. The dose-response curves were similar in both groups, with the RHD group at a lower level. The results obtained with tonsil-derived lymphocytes, in particular, indicate that this lower response Nanograms FIGURE 3 Blastogenic responise of peripheral blood lymphocytes to streptococcal blastogen A. Lymphocyte stimulation was measured and results reported as described in Fig. 1 . 0, RHD subjects; 0, control subjects.
would not be overcome with increased amounts ofblastogen A since similar levels of thymidine incorporation were obtained at both of the higher doses. The RHD lymphocytes are apparently refractory to the streptococcal blastogen as compared with those of the control group.
A similar result was observed when lymphocytes were challenged with streptococcal nuclease B (Figs. Nanograms FIGURE 2 Blastogeniic response of tonsillar lymphocytes to PHA. Lymphocyte stimilulationi was cmeasured and results reported as described in Fig. 1 . 0, RHD subjects; 0, control subjects. FIGURE 4 Blastogenic responise of tonsillar lymphocytes to streptococcal blastogen A. Lymphocyte stimulation was measured anid results reported as described in Fig. 1 the exterior or interior of the tonsils. Nanograms FIGURE 6 Blastogenic response of tonsillar lymphocytes to streptococcal nuclease B. Lymphocyte stimulation was measured and results reported as described in Fig. 1 . 0, RHD subjects; 0, control subjects.
DISCUSSION
The lymphocyte blastogenic response to two homogeneous streptococcal extracellular products was signifi- cantly lowered in patients with rheumatic heart disease as compared with nonrheumatic subjects. The reactivity to PHA, a polyclonal T cell mitogen, was however, no different in RHD and control subjects. The differential response in RHD subjects is evidently not due to a general decrease in T cell responsiveness but may be specifically associated with reaction to streptococcal antigens. A nonstreptococcal antigen, C. albicans, stimulated little or no blastogenic response in the assay system used; thus it is not established whether the lowered response is associated only with streptococcal antigens. However, the results are consonant with previous reports of a relatively depressed response in peripheral blood lymphocyte transformation to streptococcal antigens in patients with ARF or RHD (2-6). In contrast to the suppressed cellular immune response in patients with RHD reported here, Read et al. (7) described an exaggerated cellular reactivity in patients with rheumatic fever which lasted for at least 5 yr after the initial attack. Several factors may account for the differences in these two studies. The technique of migration inhibition of peripheral blood leukocytes was used by Read et al. (7), whereas we used lymphocyte incorporation of tritiated thymidine as a measure of cellular response. Moreover, these workers examined responses to particulate components of the In interpreting our results it was considered that a lower response would be expected in RHD subjects who might be protected from exposure to streptococcal antigens by antimicrobial prophylaxis. This possibility is not supported by the indirect evidence available: (a) the levels of antistreptococcal antibodies in the patients with RHD are not greatly or regularly different from the control group; (b) similar frequencies and distributions of streptococci were found in the tonsils of RHD and control subjects; (c) patient interviews indicated that many were not consistent in the main- Cellular Immune Responses in Rheumatic Heart Disease tenance of prophylaxis. As judged by these findings, the exposure of the RHD group to streptococci was not significantly different and presumably their immune systems had been presented with a streptococcal challenge generally comparable to that of controls. The previously reported observations of lowered responsiveness to streptococcal antigens could have been due to a dose-response phenomenon, but the present results obviate this possibility. In the studies with lymphocytes from patients with ARF (2, 3, 5, 6 ) the results might have included an artifactual lowering of lymphoproliferation by the effect of aspirin (20) or steroids (21) , but this was not a factor in the responses of the RH D patients reported here, none of whom were receiving or had recently received these drugs. These findings suggest that the lymphocytes from RHD subjects are relatively refractory to stimulation by streptococcal antigens, or are different in the kinetics of their proliferative response.
With the mitogens and antigens used in the present study, tonsillar and peripheral blood lymphocytes reacted in a similar manner. This confirms and extends the results of Drucker et al. (14) using less purified preparations. The similarity in response suggests that the tonsillar lymphocytes are subject to the same influences that modulate the response ofperipheral blood lymphocytes. It has been reported that tonsillar lymphocytes, in some patients, exist in a preactivated state with an elevated level of spontaneous lymphoproliferation (14) . In such patients, the blastogenic response to mitogen (PHA) or antigen is depressed in both tonsillar and peripheral blood lymphocytes. This phenomenon was not observed in the present study; although the unstimulated response was somewhat higher in tonsillar than peripheral blood lymphocytes there was no decrease in the stimulated tonsillar response.
A suggested mechanism for the lowered response to streptococcal antigens in RHD subjects was that the responding lymphocytes in the blood of control subjects are somehow sequestered in sites where they interact with antigens (4). Tonsils can be such a reservoir of streptococcal antigens but in fact, in the present study hemolytic streptococci were recovered with approximately equal frequency from the tonsils of both groups, and the response of the tonsillar lymphocytes to streptococcal antigens in the RHD subjects was low compared to that in the peripheral blood. Certainly, if lymphocytes are sequestered in tonsillar tissue, those isolated are not as responsive as those from control subjects.
Crude culture filtrates of group A streptococci have been shown to stimulate the proliferation of T lymphocytes (22) . Purified streptococcal blastogen A also stimulates blastogenesis in T cell populations although interaction with non-T cells appears necessary for maximal reactivity. 4 The streptococcal products used in the present study represent one protein (blastogen A) with relatively nonspecific lymphocyte stimulating properties and one (nuclease B) which would specifically stimulate transformation of primed lymphocytes. The results clearly indicate that the lowered response characteristic of patients with RHD occurs with both proteins. Since blastogen A acts as a polyclonal T cell stimulator, this suggests that the depression in response is not limited to specifically primed lymphocytes. Some degree of specificity is, however, indicated by the identity of response of the RHD and control subjects to PHA. It is possible that the responsiveness in RHD is affected by a deficiency in a responding subpopulation. Williams et al. (23) have reported an increased proportion of T cells forming "active rosettes" in patients with ARF but did not report on patients with inactive RHD. Another mechanism could involve a suppressor cell interaction. The blastogenic response to a crude preparation of extracellular products from group C streptococci as well as to partially purified preparations of group A extracellular nucleases is associated with an increased frequency of human histocompatibility antigen (HLA) B5 (24) . In mice, the immune response genes are closely linked to HLA loci, and the formation of specific suppressor cells is involved in the immune response gene controlled response to a specific antigen (25) . If the HLA association of response to streptococcal antigens in man actually involves immune response genes, these might be related to the generation of suppressor cells resulting in the lowered response observed in RHD subjects.
The understanding of the mechanism of altered cellular immune response clearly requires further investigation that may ultimately lead to insights into the pathogenesis of RHD.
